Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. - Pinzone MR; Zanghì AM; Rapisarda L; D'Agata V; Benanti F; Spartà D; Nunnari G; Cacopardo B (European review for medical and pharmacological sciences, 2014)